A HIGH LEVEL OF VOLLEYBALL PRACTICE ENHANCES BONE FORMATION MARKERS AND HORMONES IN PREPUBESCENT BOYS

Objectives: To examine the effects of volleyball on hormones and biochemical markers before puberty. Methods: 130 prepubescent white boys were investigated in this study. 80 prepubescent volleyball players were divided into two groups according to the duration of training: 40 (age: 11.5 ± 0.6 years), representing the high-level training group (HLG), completed 6 to 8 hours of training/week; 40 (age: 11.2 ± 0.7 years), representing the low-level training group (LLG), completed 3 to 5 hours of training/week. The other 50 non-athletic boys (age: 11.3 ± 0.2 years) were used as control subjects (C). Results: Serum concentration of growth hormone (GH), insulin-like growth factor 1 (IGF-1) and carrier protein 3 (IGFBP-3), cortisol, bone formation markers (osteocalcin [OC] and bone alkaline phosphatase [BAP], and a bone resorption marker (cross-linked C-terminal telopeptide of type I collagen [CTX] were measured. No difference in CTX was observed among the three groups. However, the HLG presented higher levels of bone formation markers (OC, BAP) compared to controls. Hormonal concentrations of GH, IGF-1, IGFBP-3, and cortisol were higher in HLG than in controls. Conclusion: Volleyball did not lead to enhanced bone turnover markers and anabolic hormones of bone after a low-training level when compared to controls. Indeed, a high-training level induces enhanced bone formation markers and basal concentration of anabolic (GH, IGF-1, and IGFBP-3) and catabolic (cortisol) hormones of bone metabolism. Therefore, basal hormone concentrations and bone formation markers were directly related to the intensity and the duration of the training level

The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study.

Poverty is strongly associated with mortality from COPD, but little is known of its relation to airflow obstruction.In a cross-sectional study of adults aged ≥40 years from 12 sites (N=9255), participating in the Burden of Obstructive Lung Disease (BOLD) study, poverty was evaluated using a wealth score (0-10) based on household assets. Obstruction, measured as forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) (%) after administration of 200 μg salbutamol, and prevalence of FEV1/FVC<lower limit of normal were tested for association with poverty for each site, and the results were combined by meta-analysis.Mean wealth scores ranged from 4 in Blantyre (Malawi) and Kashmir (India) to 10 in Riyadh (Saudi Arabia), and the prevalence of obstruction, from 16% in Kashmir to 3% in Riyadh and Penang (Malaysia). Following adjustments for age and sex, FEV1/FVC increased by 0.36% (absolute change) (95%CI: 0.22, 0.49; p<0.001) per unit increase in wealth score. Adjustments for other confounders reduced this effect to 0.23% (0.11, 0.34), but even this value remained highly significant (p<0.001). Results were consistent across sites (I(2)=1%; phet=0.44). Mean wealth scores explained 38% of the variation in mean FEV1/FVC between sites (r(2)=0.385, p=0.031).Airflow obstruction is consistently associated with poverty at individual and community levels across several countries

Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world. The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants. The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry. On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected

Effects of Ramadan observance on repeated cycle ergometer sprinting and associated inflammatory and oxidative stress responses in trained young men

Aim: was to assess the effects of Ramadan observance upon repeated sprints and associated inflammatory and oxidative stress responses. Methods: Ten young trained boxers were tested during a control period (C), at the end of the first week (R-1), and during the fourth week of Ramadan observance (R-4). On each occasion, they performed three vertical jumps, 10 x 6 s repeated sprints on a cycle ergometer, followed by three final vertical jumps 1 min after. Surface electrodes measured the EMG activity of the vastus lateralis during jumps performed before and after sprinting. Oxidative stress (malondialdehyde, total antioxidant and catalase), inflammatory markers (C-reactive protein, Interleukin-6 and homocysteine), muscle damage (CPK and LDH) and blood glucose were measured at rest and after completing the exercise protocol. Results: The overall sprint performance was reduced at R-1 compared to C (-6.3 ± 1.2%, p = 0.025), but had recovered by R-4. Jump height decreased after the repeated sprints (

Overdiagnosis of COPD in subjects with unobstructed spirometry

Background: There are several reports on the underdiagnosis of COPD, while little is known about COPD overdiagnosis and overtreatment. We describe the overdiagnosis and the prevalence of spirometrically defined false-positive COPD, as well as their relationship with overtreatment across 23 population samples in 20 countries participating in the BOLD Study between 2003 and 2012. Methods: A false-positive diagnosis of COPD was considered when participants reported a doctor's diagnosis of COPD, but postbronchodilator spirometry was unobstructed (FEV1/FVC > LLN). Additional analyses were performed using the fixed ratio criterion (FEV1/FVC < 0.7). Results: Among 16,177 participants, 919 (5.7%) reported a previous medical diagnosis of COPD. Postbronchodilator spirometry was unobstructed in 569 subjects (61.9%): false-positive COPD. A similar rate of overdiagnosis was seen when using the fixed ratio criterion (55.3%). In a subgroup analysis excluding participants who reported a diagnosis of "chronic bronchitis" or "emphysema" (n = 220), 37.7% had no airflow limitation. The site-specific prevalence of false-positive COPD varied greatly, from 1.9% in low- to middle-income countries to 4.9% in high-income countries. In multivariate analysis, overdiagnosis was more common among women, and was associated with higher education; former and current smoking; the presence of wheeze, cough, and phlegm; and concomitant medical diagnosis of asthma or heart disease. Among the subjects with false-positive COPD, 45.7% reported current use of respiratory medication. Excluding patients with reported asthma, 34.4% of those with normal spirometry still used a respiratory medication. Conclusions: False-positive COPD is frequent. This might expose nonobstructed subjects to possible adverse effects of respiratory medication.info:eu-repo/semantics/publishedVersio

COPD: should diagnosis match physiology?

We are very grateful to Dr. Vanfleteren and colleagues for commenting on our data regarding overdiagnosed COPD2 and for putting this evidence into the framework of the current understanding of the disease. Based on the data presented on overdiagnosis, and on prior Burden of Obstructive Lung Disease (BOLD) observations on underdiagnosis,3 we truly believe that our worldwide community of pulmonary specialists could do much better in caring for this extremely prevalent and devastating disease. Overall, our data indicate that for one patient with a “matched” COPD diagnosis (ie, the presence of postbronchodilator airways obstruction and a positive recall of such a diagnosis), there is always another “mismatched,” false-positive patient with COPD. This patient possibly experiences all the untoward consequences, such as receiving expensive and possibly harmful medication, and missing chances for treatment of cardiac disease or asthma. On the contrary, for each “known” patient with COPD who has a poorly reversible airway obstruction, there are four to five other patients out there with yet undetected airways obstruction. Again, we are missing opportunities in these patients for smoking intervention, symptom relief, and prolongation of their lives.info:eu-repo/semantics/publishedVersio